Richard H. Chin
Corporate Officer/Principal at The University of California, San Francisco
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ivan M. Lieberburg | M | 74 |
Balance Therapeutics, Inc.
 Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA.
The University of California, San Francisco
| 36 years |
| Jessica Chao | F | - |
The University of California, San Francisco
| 10 years |
| Robert Williams | M | 75 |
The University of California, San Francisco
| 14 years |
| Harry K. Genant | M | 81 |
The University of California, San Francisco
| - |
| Stephen Sherwin | M | 75 |
The University of California, San Francisco
| - |
| Aleksandar Rajkovic | M | - |
The University of California, San Francisco
| - |
| Fady Malik | M | 59 |
The University of California, San Francisco
| 24 years |
| Stanley B. Prusiner | M | - |
The University of California, San Francisco
| - |
| John F. Feilders | M | - |
The University of California, San Francisco
| - |
| David A. Larson | M | 83 |
The University of California, San Francisco
| 38 years |
| Israel Charo | M | 74 |
The University of California, San Francisco
| 33 years |
| Peter R. Carroll | M | - |
The University of California, San Francisco
| - |
| Dean Ornish | M | - |
The University of California, San Francisco
| - |
| Trevor Mundel | M | - |
Bill & Melinda Gates Foundation Trust
 Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | 13 years |
| Chris Wilson | M | - |
Bill & Melinda Gates Foundation Trust
Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | 15 years |
| Carol L. Moss | F | - |
The University of California, San Francisco
| - |
| Deepak Srivastava | M | 57 |
The University of California, San Francisco
| - |
| Narayana S. Ambati | M | - |
The University of California, San Francisco
| - |
| Robert L. Goldberg | M | - |
The University of California, San Francisco
| - |
| Jack Taunton | M | - |
The University of California, San Francisco
| - |
| Matthew Jacobson | M | - |
The University of California, San Francisco
| 22 years |
| Robin Kate Kelley | M | - |
The University of California, San Francisco
| 15 years |
| Irene McGlynn | F | - |
The University of California, San Francisco
| - |
| Ramona Doyle | M | 65 |
The University of California, San Francisco
| 13 years |
| Saptarsi Haldar | M | - |
The University of California, San Francisco
| - |
| Sheng Ding | M | - |
The University of California, San Francisco
| - |
| Benoit G. Bruneau | M | - |
The University of California, San Francisco
| - |
| Risa Kagan | M | - |
The University of California, San Francisco
| - |
| Jeffrey Olgin | M | - |
The University of California, San Francisco
| - |
| Andrej Sali | M | - |
The University of California, San Francisco
| - |
| Daniel Schwartz | M | 68 |
The University of California, San Francisco
| - |
| Krystof S. Bankiewicz | M | - |
The University of California, San Francisco
| - |
| Robert Wachter | M | 66 |
The University of California, San Francisco
| - |
| Catherine Lynch Gilliss | M | 75 |
The University of California, San Francisco
| 7 years |
| Adam Gazzaley | M | 55 |
The University of California, San Francisco
| - |
| Jack D. McCue | M | - |
The University of California, San Francisco
| - |
| Daniel R. Hightower | M | - |
The University of California, San Francisco
| - |
| Hsiao Lieu | M | 53 |
The University of California, San Francisco
| - |
| David A. Kessler | M | 72 |
The University of California, San Francisco
| 21 years |
| James Pennington | M | 81 |
The University of California, San Francisco
| 38 years |
| Philip J. Barr | M | - |
The University of California, San Francisco
| - |
| James A. Wells | M | 73 |
The University of California, San Francisco
| - |
| Joel Sklar | M | 74 |
The University of California, San Francisco
| - |
| Bruce M. McNamara | M | - |
The University of California, San Francisco
| - |
| Harvey J. Anderson | M | 61 |
The University of California, San Francisco
| - |
| Leslie Z. Benet | M | 86 |
The University of California, San Francisco
| 55 years |
| Steven L. Shafer | M | - |
The University of California, San Francisco
| - |
| Cynthia J. Kenyon | M | 69 |
The University of California, San Francisco
| - |
| Laurence Corash | M | 80 |
The University of California, San Francisco
| 42 years |
| Kenneth T. Derr | M | 87 |
The University of California, San Francisco
| - |
| Harold Messmer | M | 78 |
The University of California, San Francisco
| - |
| Rebecca Coleman | M | - |
The University of California, San Francisco
| - |
| Kristen Hege | M | 60 |
The University of California, San Francisco
| 28 years |
| Marcus A. Conant | M | 88 |
The University of California, San Francisco
| - |
| Philip D. Cotter | M | - |
The University of California, San Francisco
| - |
| Nanci Bakar Fredkin | F | - |
The University of California, San Francisco
| - |
| Carol Brosgart | M | 72 |
The University of California, San Francisco
| - |
| Hal Barron | M | 62 |
The University of California, San Francisco
| - |
| Philip E. Wolfson | M | 79 |
The University of California, San Francisco
| 38 years |
| Michael Rowbotham | M | - |
The University of California, San Francisco
| - |
| Andrew Woeber | M | 56 |
The University of California, San Francisco
| - |
| Vera Price | M | - |
The University of California, San Francisco
| - |
| Kenneth Hao | M | 55 |
The University of California, San Francisco
| - |
| Michael McGrath | M | - |
The University of California, San Francisco
| - |
| Andrew N. Goldberg | M | - |
The University of California, San Francisco
| - |
| David J. Soffa | M | - |
The University of California, San Francisco
| - |
| Eugene de Juan | M | - |
The University of California, San Francisco
| - |
| H. Perez | M | 74 |
The University of California, San Francisco
| - |
| Jeffrey Waldman | M | - |
The University of California, San Francisco
| - |
| Robert Niklewicz | M | - |
The University of California, San Francisco
| - |
| Tony Chou | M | 63 |
The University of California, San Francisco
| - |
| Pamela Palmer | M | 61 |
The University of California, San Francisco
| 28 years |
| James Bennan | M | - |
The University of California, San Francisco
| - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark J. Ahn | M | 61 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | 10 years |
| William Schwieterman | M | 66 | 13 years | |
| Mark W. Schwartz | M | 68 |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | 6 years |
| Anthony J. Gringeri | M | 71 | 5 years | |
| Patricia Stonesifer | F | 67 |
Bill & Melinda Gates Foundation Trust
Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | 13 years |
| Gary Titus | M | 64 | - | |
| Stephen F. Ghiglieri | M | 63 |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | - |
| John Kollins | M | 61 | 2 years | |
| Kwang S. Lee | M | - |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | - |
| Remy Bernarda | F | - |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | - |
| Ryan Dunlap | M | 54 |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | 3 years |
| Andrew Gengos | M | 59 | 4 years | |
| Robert A. Swanson | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Ian Clark | M | 62 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| Noah Beerman | M | 62 |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | 2 years |
| Douglas Love | M | 56 |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 12 years |
| William Ashton | M | 73 |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | 4 years |
| Ryan Watts | M | 48 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| Herbert D. Montgomery | M | 81 |
PATH Drug Solutions
Bill & Melinda Gates Foundation Trust
Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | 10 years |
| Patricia Ann Walicke | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Markus Gemuend | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | - |
| Steven Shak | M | 73 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 11 years |
| David Nagler | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Steven Kriegsman | M | 82 |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | 7 years |
| Myrtle Potter | F | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 years |
| Dennis J. Henner | M | 72 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| June Lee | M | 58 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard H. Chin
- Personal Network
